V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Senior Manager – Centre Engagement Lead - CEL

Implementation & Technical Account ManagementConfirmed live in the last 24 hours
Full-timeNetherlandsNo salary listedHybrid

About the Job

Requirements

  • Outstanding communication skills and the ability to support customers on operational onboarding, contracting, technical readiness, training coordination, and process support.
  • Strong negotiation and contracting experience gained in similar or other roles.
  • Ability to coordinate a cross-functional project team and ensure deliverables are tracked and managed in a timely fashion, knowing when to escalate issues.
  • Comfort navigating uncertainty and managing demands in a dynamic and fast-growing organization.
  • Entrepreneurial approach to problem solving and a hands-on attitude.
  • Superior project management, organizational, and time management skills, with the ability to prioritize and reprioritize as new insights emerge.
  • Solid understanding of the compliance framework with a high level of integrity.
  • Good IT skills, including Microsoft Office (Word, Excel, PowerPoint, and Outlook).
  • Fluent in English, with excellent written and verbal skills and the ability to present concisely to senior leaders.
  • Bachelor's degree.
  • Extensive experience in the biotech/pharmaceutical or medical technology environment, with a track record of successful cross-functional teamwork.
  • Demonstrated successful negotiation and contracting experience in previous roles.

Responsibilities

  • Identify transplant centres in the Netherlands and Belgium to become Authorized Treatment Centers (ATCs) for Vertex's gene-editing technology.
  • Coordinate a cross-functional Vertex team to contract and onboard ATCs, and support healthcare professionals and patients throughout the treatment journey, from patient referral to infusion and post-infusion support.
  • Assess and recommend potential ATCs to activate for Vertex's gene-editing technology in Benelux.
  • Act as the primary point of contact for all stakeholders at ATCs and proactively support multiple ATCs.
  • Lead the ATC contracting process, aligning Vertex internal cross-functional teams, especially Legal, Quality, and Heme Commercial, with external ATC stakeholders to execute contracts in a timely manner.
  • Define the onboarding strategy from ATC activation to order readiness, including training on Vertex's order portal and training ATC apheresis and infusion teams.
  • Engage with ATCs, physicians, and management teams to support centre onboarding and activation and provide ongoing support for ATC activities related to Vertex's gene-editing technology.
  • Oversee and coordinate ongoing ATC training measures or audits to ensure consistent, high-quality service.
  • Develop and own ATC operational readiness plans and objectives, excluding sales, and regularly report progress against goals.
  • Guide ATCs so patients can be treated with the gene-editing technology rapidly and easily after identification.
  • Serve as the first point of contact for issues at ATC level and work quickly to find acceptable solutions for ATCs and Vertex Pharmaceuticals.
  • Play a leading role in the cross-functional launch team, drawing on insights gained in the position.
  • Periodically present progress toward goals to senior leaders and recommend improvements to systems and processes to headquarters teams overseeing commercialization of Vertex's gene-editing technology.
  • Travel occasionally to other locations internationally for meetings and events.

Desired Qualifications

  • Experience in cell and gene therapy is desirable but not mandatory.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs